Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ricevuto

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysisG Di Lorenzo, R Autorino, G Bruni, et al.
Tumori|August 9, 2003
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?]E Ricevuto, P Marchetti, K Cannita, et al.
Oncology Reports|April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II studyM F Morelli, A Santomaggio, E Ricevuto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative StudyB Iacopetta, A Russo, V Bazan, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2009
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysisG Di Lorenzo, R Autorino, G Bruni, et al.
Tumori|August 9, 2003
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?]E Ricevuto, P Marchetti, K Cannita, et al.
Oncology Reports|April 30, 2010
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II studyM F Morelli, A Santomaggio, E Ricevuto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2006
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative StudyB Iacopetta, A Russo, V Bazan, et al.
Pageof 5